Mayne Pharma Group Ltd (MYX)

Currency in AUD
3.010
-0.010(-0.33%)
Closed·

MYX Earnings

Latest Release
Aug 26, 2026
EPS / Forecast
0.31 / --
Revenue / Forecast
86.5M / --
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
2026/09--/----/------Free Sign Up
2026/060.310/--86.50M/------Free Sign Up
2026/03--/--85.20M/------Free Sign Up
2025/12-0.150/--212.07M/210.70M--+0.65%Free Sign Up
2025/09--/----/------Free Sign Up
2025/06-0.890/--195.04M/202.70M---3.78%Free Sign Up
2025/03-0.250/--86.80M/------Free Sign Up
2024/12-0.250/-46.30213.05M/161.00M+99.46%+32.33%Free Sign Up
2024/09--/--132.50M/------Free Sign Up
2024/06--/-27.10--/176.50M----Free Sign Up

All numbers in AUD

Mayne Pharma Group Ltd Earnings Call Summary for H2/2026

  • Mayne Pharma reported FY2026 revenue of AUD 383.7M (down 6%), but gross margin expanded 411 bps to 64.7% on improved product mix and pricing.
  • Underlying EBITDA fell 27% to AUD 34.2M due to higher sales/marketing spend, FX headwinds, and litigation costs from Cosette dispute.
  • Women's health products BIJUVA, IMVEXXY, and NEXTSTELLIS grew; new distribution platform DistributeRx added 5,000 prescribers, expanding capacity.
  • Management expects FY2027 margin improvement from women's health growth, reduced one-off costs, and resolution of ANNOVERA product returns.
  • Stock unchanged at $3.17; company remains unprofitable with cash position declining to AUD 80M from AUD 100.4M year-over-year.
Last Updated: 2026-08-26, 08:24 p/m
Read Full Transcript

FAQ

What Is Mayne Pharma's Earnings Per Share (TTM)?

The Mayne Pharma EPS (TTM) is 0.271.

When Is The Next Mayne Pharma Earnings Date?

Mayne Pharma will release its next earnings report on Nov 19, 2026.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.